Baltic Fracture Competence Centre


March 2016 -
February 2019

Completed

Policy area:
Innovation
1. Innovation 1.1 R&I infrastructures

BFCC

The project BFCC engaged four hospitals supported by business development organisations and universities in creating a joint registry to store and process data about bone fractures in four countries. Medical companies used this data for improving their products to offer better treatment possibilities for patients, thus preparing our ageing society for the numbers of bone fractures and linked health disorders to increase.

 

The challenge

More fractures and stronger need for medical innovation in ageing societies

The number of bone fractures and linked health disorders are expected to increase in the future due to an ageing society. The annual number of fractures in the EU is estimated to rise from 3.5 million in 2010 to 4.5 million in 2025. Due to more age-related fractures and co-morbidities such as osteoporosis or post-surgery complications like infections, the need for innovative products and clinical treatment procedures is increasing. These innovations are meant to reduce the total cost of care or improve its quality.

Companies lack knowledge to offer better medical products

Companies that offer implants, imaging, pharmaceuticals, wound care or single-use surgery devices are facing various difficulties, e.g. in understanding the clinical needs, in following up on the effectiveness of treatment, in reducing costs and in offering innovation on the market. As around 50 % of new products are initiated by clinicians, the companies need direct access to hospitals. This allows them to collaborate within needs assessment, pre-clinical research, product development, clinical trials, post-market follow up studies and health technology assessment.

 

HIGHLIGHTS

A digital registry to collect missing data and establish new links

In order to accommodate all these health and business needs, the BFCC project encouraged four hospitals in Germany, Estonia, Lithuania and Poland to join forces in the Transnational Fracture Registry Platform. The platform helped to acquire, store and process fracture data. The platform allowed to compare the clinical process and quality of outcomes across organisations and countries. At the end of the project the Fracture Registry contained several hundred complete data sets. As the work continues this number is growing every day and delivering new evidence.

Fracture Registry in action

Through practical usage of data gathered on the Transnational Fracture Registry Platform the project has improved the understanding of innovation processes in the medical technology industry. This way 48 companies gained opportunities to enter into a dialogue with the involved clinics and carry out research in fracture management. These businesses got a chance to align their innovation efforts with clinical requirements as well as gained access to the most recent findings in the fracture research.

The collaboration standards were tested, evaluated and optimized in the fields of infections, diagnostics and post-surgery complications. These tests featured different aspects such as a new classification system for fracture complications, a clinical study about a new commercially available bone substitute that elutes antibiotics, and a new method for hip fractures applied in a hospital setting. The companies involved gained insight into innovation cycles between industry and clinics in different Baltic Sea region countries and expanded their networks for future clinical industry cooperation. 

Better treatment in the future

With EUR 3 million support from the European Union, the Interreg project BFCC has created a novel tool that gave a new dimension to cooperation of hospitals and medical technology industry. This in turn is likely to change treatment outcomes for thousands of patients who will experience fracture in the future.

 

 

Project Stories

Budgets

Total
€ 3.60
million
Erdf
€ 2.77
million
Eni + Russia
€ 0.00
million
Norway
€ 0.00
million

PARTNERS

Outputs

Social Media

CONTACTS

Project manager

Life Science Nord Management GmbH

Anna Eckers

+49 431 9089 -6858

Legal representative

Life Science Nord Management GmbH

Hinrich Habeck

4 940 047 196 400

Financial manager

DSN - Connecting Knowledge

Daniel Klose

49 431 99 69 66 640

Communication manager

DSN - Connecting Knowledge

Gesine Stück

+49 431 99 69 66-80